|Labeler:||Epic Pharma, LLC|
|Product Type:||Human Prescription Drug|
|Dosage Form:||Oral Capsule|
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.
NDC Package Codes:
- 42806-264-01: 100 CAPSULE IN 1 BOTTLE (42806‑264‑01)
- 42806-264-05: 500 CAPSULE IN 1 BOTTLE (42806‑264‑05)
- 5 mg
- Silicon Dioxide
- Starch, Corn
- Lactose Monohydrate
- Cellulose, Microcrystalline
- Polyethylene Glycol 8000
- Sodium Lauryl Sulfate
- Titanium Dioxide
- Ferric Oxide Red
- Ferrosoferric Oxide
- D&c Yellow No. 10
- Fd&c Blue No. 1
- Fd&c Blue No. 2
- Fd&c Red No. 40
- Butyl Alcohol
- Propylene Glycol
- Calcium Channel Antagonists [MoA]
- Dihydropyridine Calcium Channel Blocker [EPC]
- Dihydropyridines [CS]
Related Products:Based on records with the same trade name.
- 42806-263 Isradipine 2.5 mg Oral Capsule by Epic Pharma, LLC
- 16252-539 Isradipine 2.5 mg Oral Capsule by Cobalt Laboratories
- 16252-540 Isradipine 5 mg Oral Capsule by Cobalt Laboratories
- 50268-454 Isradipine 2.5 mg/1 Oral Capsule by Avpak
- 50268-455 Isradipine 5 mg/1 Oral Capsule by Avpak
- 60429-385 Isradipine 2.5 mg Oral Capsule by Golden State Medical Supply, Inc.
- 60429-386 Isradipine 5 mg Oral Capsule by Golden State Medical Supply, Inc.
- 68151-1333 Isradipine 5 mg Oral Capsule by Carilion Materials Management
- 68462-807 Isradipine 2.5 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA
- 68462-808 Isradipine 5 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA
NDC QR CodeScan the QR code below to easily reference this data in the future:
< Prev: 42806-263Next: 42806-296 >
Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.